Search Results - "Wei, John X."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Impact of race and ethnicity on early mortality in multiple myeloma: a SEER analysis by Wei, John X, Shastri, Aditi, Sica, R Alejandro, Mantzaris, Ioannis, Kornblum, Noah, Shah, Urvi, Janakiram, Murali, Gritsman, Kira, Verma, Amit, Goldfinger, Mendel, Cooper, Dennis, Shah, Nishi

    Published in Haematologica (Roma) (01-05-2024)
    “…Over the past two decades, there have been significant advances in the treatment of multiple myeloma which has led to an improvement in overall survival.1,2…”
    Get full text
    Journal Article
  2. 2

    Bcl-2 inhibition in the treatment of hematologic malignancies by Wei, John X., Konopleva, Marina

    Published in Frontiers in hematology (04-12-2023)
    “…Apoptosis is a tightly regulated process of cell death occurring through extrinsic and intrinsic pathways. The Bcl-2 family of proteins is implicated in the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Adjuvant therapy in localized vs regional biliary tract cancers: A SEER analysis by Wei, John X, Wang, Christina, Pintova, Sofya

    Published in Journal of clinical oncology (01-06-2023)
    “…e16221 Background: Biliary Tract Cancers (BTC) are aggressive malignancies. Treatment of early-stage disease involves surgical resection, but whether adjuvant…”
    Get full text
    Journal Article
  5. 5

    Predictive factors for academic oncology career placement by Wei, John X., Yan, John, Beltran, Santiago, Castellucci, Enrico

    Published in Journal of clinical oncology (01-06-2024)
    “…9039 Background: Oncology is a discipline that has witnessed rapid expansion with new therapeutics and practices. Following this trend, training programs are…”
    Get full text
    Journal Article
  6. 6

    Assessing Epidemiological Differences in Myelofibrosis: A Comparative Study of a Single-Center Cohort and the SEER National Database by Yan, John, Wei, John X, Verma, Amit, Shah, Nishi, Goel, Swati

    Published in Blood (02-11-2023)
    “…Background Myelofibrosis (MF) is a rare class of BCR-ABL negative myeloproliferative neoplasms characterized by clonal proliferation of hematopoietic stem…”
    Get full text
    Journal Article
  7. 7

    Access to care in patients with pancreatic adenocarcinoma by race/ethnicity in an academic center in the Bronx, NY by Brodsky, Michael, Wei, John X, Castagna, Francesco, Jou, Erin, Shusterman, Michael, Goel, Sanjay, Acuna-Villaorduna, Ana

    Published in Journal of clinical oncology (01-06-2022)
    “…e16280 Background: Racial disparities in the overall survival (OS) of patients with pancreatic adenocarcinoma (PDAC) have been previously reported. Large…”
    Get full text
    Journal Article
  8. 8

    Real-world analysis of the impact of race on immunotherapy in non-small cell lung cancers by Lee, Matthew, Miao, Emily, Wang, Shuai, Zhang, Frank, Wei, John X, Chung, Julie, Xue, Xiaonan, Halmos, Balazs, Cheng, Haiying

    Published in Journal of clinical oncology (01-06-2022)
    “…e18692 Background: Immunotherapy (IO) has become an essential component in the treatment of NSCLC. However, there is limited data on the clinical impact of IO…”
    Get full text
    Journal Article
  9. 9

    Clinical efficacy of frontline immunotherapy (IO) in ethnic-minority patients (pts) with metastatic NSCLC by Lee, Matthew, Liu, Jianyou, Miao, Emily, Wang, Shuai, Zhang, Frank, Wei, John X, Chung, Julie, Xue, Xiaonan, Halmos, Balazs, Hosgood, Dean, Cheng, Haiying

    Published in Journal of clinical oncology (01-06-2023)
    “…e21063 Background: Since minority pts have been historically underrepresented in key IO trials, knowledge on the clinical use of IO in ethnic-minority pts with…”
    Get full text
    Journal Article
  10. 10
  11. 11